Morgan Stanley Virios Therapeutics, Inc. Transaction History

Morgan Stanley

  • $1.39 Trillion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$0.14 - $4.99 $2,128 - $75,852
-15,201 Closed
0 $0
Q3 2024

Nov 14, 2024
BUY
$0.17 - $0.29 $34 - $58
201 Added 1.34%
15,201 $2,000
Q2 2023

Aug 14, 2023
BUY
$0.35 - $1.94 $5,250 - $29,100
15,000 New
15,000 $20,000
Q4 2022

Feb 14, 2023
SELL
$0.24 - $0.39 $1,110 - $1,804
-4,627 Reduced 99.76%
11 $0
Q1 2022

May 13, 2022
BUY
$4.48 - $6.92 $20,778 - $32,094
4,638 New
4,638 $21,000

Others Institutions Holding VIRI

# of Institutions
4
Shares Held
36.1K
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email